Skip to content

Effects of Regional Nerve Block on Cancer Recurrence

Effects of Regional Nerve Block on Cancer Recurrence

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03134430
Enrollment
400
Registered
2017-05-01
Start date
2017-07-10
Completion date
2023-05-01
Last updated
2018-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Patient

Keywords

Regional nerve block, cancer recurrence

Brief summary

It has been reported local anesthetics could inhibit tumor cell proliferation, metastasis and invasion ability,but it is still lack of clinical evidence. Our study aims to explore the effects of regional nerve block on cancer recurrence and the mechanism.

Detailed description

1. To study the effects of TAP block under ultrasound guide on the recurrence of gastric carcinoma, colon cancer, rectal carcinoma and liver cancer and the underlying mechanisms. 2. To clarify the effects of Lateral thoracic nerve block under ultrasound guide on the recurrence of lung cancer and the underlying mechanisms.

Interventions

OTHERNormal saline

Injection of Normal saline around peripheral nerve

OTHERperipheral Nerve block

Injection of local anesthetics around peripheral nerve

Sponsors

Luo Foquan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

the patients in treatment group will received reginoal nerve block with 0.35% Ropivacane and 0.5% lidocaine in normal saline under ultrasound guide, while those in control group received equal volume of normal saline.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with primary cancer undergoing elective surgery under general anesthesia

Exclusion criteria

* Disagree to participate,drop out,lose track, infectious abdominal wall,abnormal puncture point,coagulation dysfunction,allergy of local anesthetic ,immune disease,cancer metastasis,mental disease, acute and chronic infectious disease or other severe disease.

Design outcomes

Primary

MeasureTime frameDescription
the effect of nerve block on the cancer recurrence rate and survival rate postoperationup to 5 years after surgeryto trace cancer recurrence after tumor resection with CT scaning and tumor biological maker test for 5 years

Secondary

MeasureTime frameDescription
dosage of intraoperative anestheticintraoperative periodRecord the propofol and remifentanil during the operation
the effect of nerve block on the percentage and classification of immunocyte and content of cytokinesat 0h, 24h, 48h after nerve blockpercentage and classification of immunocyte will be detected by Use flow cytometry, and cytokines will be detected by ELISA
VAS after operationat 24h, 48h after nerve blockAssess the visual analogue scale 24,48h after nerve block
activity after operationup to 2 weeksObserve recovery time of gastrointestinal function and off-bed activity after nerve block
Hospital stayup to 4 weeks after surgeryObserve length of hospital stay

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026